Topics

Tetraphase Pharmaceuticals to Present Data at the 22nd Annual MAD-ID Meeting

07:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions, today announced five data present...

Other Sources for this Article

Media and Investor Contact:
Jennifer Viera
jviera@tphase.com
617-600-7040

NEXT ARTICLE

More From BioPortfolio on "Tetraphase Pharmaceuticals to Present Data at the 22nd Annual MAD-ID Meeting"

Quick Search

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...